Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	23^rd May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,828,122 (2.110%)		-
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	536,000 (0.234%)		1,686,000 (0.737%)
Total	5,364,122 (2.345%)		1,686,000 (0.737%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

b. Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
Purchase	215	100.21
Sale	129	100.80
Purchase	7	100.62
Purchase	100	100.52
Purchase	200	100.48
Purchase	3	100.55
Purchase	100	100.54
Purchase	1	100.61
Purchase	100	100.47
Purchase	100	100.40
Purchase	100	100.19
Purchase	44	100.23
Purchase	3	100.63
Purchase	215	100.90
Purchase	2	100.67
Sale	215	100.10
Purchase	200	100.20
Sale	18	100.65
Purchase	100	100.17
Purchase	100	100.13
Purchase	2	100.68
Purchase	256	100.15
Purchase	3,313	100.62
Purchase	700	100.52
Purchase	2,852	100.58
Purchase	6	100.25
Purchase	490	100.55
Purchase	514	100.54
Purchase	1,023	100.61
Purchase	112	100.38
Purchase	100	100.40
Purchase	87	100.45
Purchase	3,988	100.34
Purchase	1,468	100.19
Purchase	18	100.24
Purchase	100	100.42
Purchase	2,497	100.14
Purchase	6,504	100.23
Purchase	12	100.31
Purchase	500	100.21
Purchase	88	100.22
Purchase	604	100.91
Purchase	3,748	100.78
Purchase	9,857	100.67
Purchase	20	100.66
Purchase	3,237	100.69
Purchase	800	100.70
Sale	35	100.10
Purchase	200	100.74
Purchase	500	100.71
Purchase	593	100.20
Purchase	100	100.05
Purchase	18	100.65
Purchase	623	100.17
Purchase	100	100.95
Purchase	216	100.12
Purchase	76	100.11
Purchase	400	100.77
Purchase	400	100.18
Purchase	1,000	100.83
Purchase	4,357	100.33
Purchase	37	100.57
Purchase	49	100.52
Purchase	28	100.64
Purchase	21	100.61
Purchase	14	100.51
Sale	149	100.10
Sale	782	100.92
Purchase	1,464	100.57
Sale	100	100.57
Purchase	400	100.62
Sale	715	100.62
Purchase	70	100.52
Sale	100	100.52
Purchase	225	100.59
Purchase	1,705	100.58
Sale	11	100.58
Purchase	557	100.60
Sale	100	100.60
Purchase	65	100.48
Sale	829	100.48
Purchase	346	100.25
Sale	100	100.25
Purchase	1,438	100.08
Purchase	436	100.55
Sale	300	100.55
Purchase	271	100.54
Sale	200	100.54
Purchase	1,000	100.61
Sale	200	100.61
Purchase	116	100.38
Sale	200	100.47
Purchase	59	100.27
Purchase	313	100.32
Purchase	27	100.40
Purchase	100	101.01
Sale	32	101.01
Purchase	1,600	100.04
Sale	781	100.04
Purchase	100	100.45
Sale	100	100.45
Purchase	389	100.37
Sale	100	100.37
Purchase	1,457	100.35
Purchase	379	100.34
Sale	4,057	100.34
Purchase	300	100.19
Sale	2,273	100.19
Purchase	361	100.28
Sale	258	100.28
Purchase	115	100.26
Sale	200	100.26
Sale	261	100.24
Sale	499	100.42
Purchase	500	100.76
Sale	3,356	100.14
Purchase	1,010	100.31
Purchase	200	100.21
Sale	241	100.21
Purchase	200	100.63
Sale	70	100.63
Purchase	3,022	100.80
Sale	100	100.29
Purchase	2,008	100.06
Sale	515	100.06
Purchase	200	100.00
Sale	1,162	100.22
Purchase	100	100.39
Sale	100	100.39
Purchase	1,135	100.91
Sale	560	100.91
Purchase	2,234	100.75
Purchase	2,577	100.51
Sale	800	100.51
Purchase	137	100.67
Purchase	9,600	100.66
Purchase	3,300	100.03
Sale	400	100.03
Purchase	400	100.50
Sale	550	100.50
Purchase	45	100.30
Sale	433	100.69
Purchase	844	100.93
Purchase	100	100.94
Sale	226	100.94
Purchase	1,323	100.10
Purchase	2,057	100.53
Sale	95	100.53
Purchase	6,715	100.84
Purchase	3,230	100.74
Purchase	809	100.73
Purchase	6	100.20
Sale	614	100.20
Purchase	1,168	100.36
Sale	284	100.36
Purchase	194	100.05
Sale	400	100.05
Purchase	100	100.81
Sale	400	100.96
Purchase	5,692	100.65
Sale	200	100.17
Purchase	1,133	100.89
Purchase	784	100.95
Purchase	262	100.07
Sale	209	100.07
Sale	551	100.02
Sale	100	100.72
Purchase	933	100.56
Sale	222	100.12
Purchase	80	100.11
Sale	101	100.11
Sale	680	100.77
Purchase	250	100.98
Sale	600	100.98
Sale	400	100.97
Sale	42	100.99
Sale	200	100.44
Sale	500	100.18
Purchase	181	100.85
Purchase	382	100.83
Purchase	709	101.00
Purchase	1	100.33
Sale	4,357	100.33
Sale	1	100.62
Sale	3	100.60
Sale	3	100.64
Sale	2	100.54
Sale	3	100.27
Sale	1	100.32
Sale	1	100.28
Sale	2	100.26
Sale	1	100.21
Sale	6	100.30
Sale	14	100.69
Sale	1	100.70
Sale	2	101.04
Sale	4	100.53
Sale	2	100.88
Sale	4	100.07
Purchase	6,214	100.57
Sale	6,214	100.57

b. Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Put Option	Purchasing	14,600	100.00	American	6/16/2023
Put Option	Purchasing	100,000	70.00	American	1/19/2024
Call Option	Selling	10,000	110.00	American	10/20/2023
Put Option	Selling	50,000	101.00	American	6/16/2023
Call Option	Selling	2,800	100.00	American	10/20/2023
Call Option	Purchasing	2,800	100.00	American	17/11/2023
Call Option	Selling	80,000	101.00	American	5/26/2023
Call Option	Purchasing	80,000	105.00	American	6/16/2023

ii. Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

b. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	24^th May 2023
Contact name	Stephen Glasper
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	201,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Written	99,500	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300,000	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	283,900	100.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	53,500	95.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	300	110.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	400	110.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	150,000	70.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	250,000	85.00	American	1/19/2024
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	50,000	90.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	50,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	125,300	110.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	150,000	100.00	American	7/21/2023
IE00BQPVQZ61	Call Option	Purchased	1,500	110.00	American	17/11/2023
IE00BQPVQZ61	Call Option	Purchased	4,500	110.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	100,000	100.00	American	12/15/2023
IE00BQPVQZ61	Call Option	Written	100,000	110.00	American	12/15/2023
IE00BQPVQZ61	Put Option	Purchased	100,000	85.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	101.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Written	2,800	100.00	American	10/20/2023
IE00BQPVQZ61	Call Option	Purchased	2,800	100.00	American	17/11/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1104001

Time of Receipt (offset from UTC): 20230524T140903+0100